Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 13 Leiomyosarcoma 8 Sarcoma, Synovial 3 Sarcoma, Alveolar Soft Part 2 Melanoma 2 Solitary Fibrous Tumors 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Sarcoma, Clear Cell 1 Parathyroid Neoplasms 1 Osteosarcoma 1 Oligodendroglioma 1 Neurofibrosarcoma 1 Liposarcoma 1 Hyperthermia 1 Histiocytoma, Malignant Fibrous 1 Hemangiosarcoma 1 Hemangioendothelioma, Epithelioid 1 Hemangioendothelioma 1 Gliosarcoma 1 Glioma, Subependymal 1 Glioma 1 Glioblastoma 1 Ependymoma 1 Chondrosarcoma, Extraskeletal Myxoid 1 Chondrosarcoma 1 Carcinoid Tumor 1 Brain Neoplasms 1 Bone Neoplasms 1 Astrocytoma 1

Interventions

Diathermy 3 Surgical Procedures, Operative 1 Radiotherapy 1 Radiation Dose Hypofractionation 1 Melphalan 1 Ifosfamide 1 Doxorubicin 1 Dacarbazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hyperthermia × Dacarbazine × Sarcoma × Clear all

NCT06835049 2025-12-30

TNT-HYPE

Swiss Cancer Institute

Phase 2 Recruiting

Hyperthermia, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡